Bo Yu
1095 Jiefang Avenue
Wuhan, 430030, China
Wuhan, 430030, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 45 publications
Ablation-induced collagen exposure enables dual-modal nuclear imaging-guided local radionuclide therapy.
Journal: Journal of nanobiotechnology
Published: January 15, 2026
Advances in Noninvasive Imaging of Natural Killer Cells.
Journal: Molecular pharmaceutics
Published: October 23, 2025
Significant Association Between Glucokinase Regulatory Protein Variants and Genetic and Metabolic Diseases.
Journal: Current issues in molecular biology
Published: July 24, 2025
Global, regional, and national burden of acute glomerulonephritis from 1990 to 2021 and future trend predictions until 2036: a systematic analysis using the Global Burden of Disease Study 2021.
Journal: Frontiers in public health
Published: March 13, 2025
Unveiling the silent threat: COVID-19 and myocardial injury.
Journal: Pharmacology & therapeutics
Published: February 21, 2025
Recent advances in transition metal-mediated/ catalyzed radiofluorination of arenes and heteroarenes for positron emission tomography.
Journal: Bioorganic chemistry
Published: October 17, 2024
The molar dose of FAPI administered impacts on the FAP-targeted PET imaging and therapy in mouse syngeneic tumor models.
Journal: European journal of nuclear medicine and molecular imaging
Published: October 12, 2024
Imaging Pulmonary Fibrosis and Treatment Efficacy In Vivo with Autotaxin-Specific PET Ligand [18F]ATX-1905.
Journal: Molecular pharmaceutics
Published: August 26, 2024
Low dose of hydroxychloroquine is associated with reduced COVID-19 mortality: a multicenter study in China.
Journal: Frontiers of medicine
Published: August 05, 2024
Clinical characteristics and risk factors for in-hospital mortality of COVID-19 patients in Hubei Province: A multicenter retrospective study.
Journal: International journal of cardiology. Heart & vasculature
Published: August 03, 2024
Targeting CXCR4/CXCL12 axis via [177Lu]Lu-DOTAGA.(SA.FAPi)2 with CXCR4 antagonist in triple-negative breast cancer.
Journal: European journal of nuclear medicine and molecular imaging
Published: December 04, 2023
Last Updated: 09/26/2026